• THZ1 as a Covalent CDK7 Inhibitor: Resolving Resistance in C

  2026-05-26

  Explore how THZ1, a covalent CDK7 inhibitor, uniquely addresses resistance mechanisms in cancer biology. This comprehensive analysis reveals its molecular advantages for transcription regulation and T-ALL research, highlighting protocol insights and implications for next-generation oncology assays.

• Baicalin and Visual Plasticity: Advanced Pathway Insights fo

  2026-05-26

  Explore how Baicalin modulates KEAP1-NRF2/HO-1 and TGF-β1/p-Smad3 pathways to restore cortical plasticity and combat cancer. This article offers a deep-dive into recent mechanistic breakthroughs and practical research protocols, grounded in new evidence.

• Cell Counting Kit-8 (CCK-8): Sensitive Cell Viability & Prol

  2026-05-25

  Cell Counting Kit-8 (CCK-8) enables rapid, sensitive measurement of cell viability and proliferation in vitro. This article details its WST-8 mechanism, benchmarking data, and best practices for cancer research and cytotoxicity assays. Evidence-based limitations and workflow integration are discussed.

• DiD (DiDC 18 (5)) for Robust Plasma Membrane Staining Workfl

  2026-05-25

  DiD (DiDC 18 (5)) delivers uniform, photostable red fluorescence for cell tracking, neuronal tracing, and migration studies—even in high-autofluorescence specimens. Its compatibility with immunofluorescence and resilience in challenging protocols make it a gold standard for advanced plasma membrane labeling.

• ML216 BLM Helicase Inhibitor: Precision Targeting in DNA Rep

  2026-05-24

  Explore how ML216, a potent BLM helicase inhibitor, enables advanced DNA repair and synthetic lethality studies in oncology. This article uniquely dissects mechanistic insights and critical assay considerations for translational cancer research.

• Chenodeoxycholic Acid: Optimizing FXR Signaling in Renal & M

  2026-05-23

  Chenodeoxycholic Acid (CDCA) stands out as a robust FXR agonist, enabling high-fidelity modeling of cholesterol and bile acid metabolism, as well as innovative renal protection assays. This guide translates recent FXR-KLF11 research into actionable workflows and troubleshooting insights for metabolic and kidney injury studies.

• Cy5 TSA Fluorescence System Kit: Redefining Sensitivity in S

  2026-05-22

  Explore how the Cy5 TSA Fluorescence System Kit enables ultrasensitive, spatially resolved detection of cell fate markers in liver development and beyond. This in-depth analysis links core TSA technology, recent advances in Hippo pathway research, and rigorous workflow optimization for high-impact immunohistochemistry and in situ hybridization.

• PLGA Nano-Adjuvant Enhances Mucosal Immunity in H9N2 Vaccine

  2026-05-22

  A novel PLGA-based nano-adjuvant (PEI-LSP-RA-PLGA) significantly boosts both systemic and mucosal immunity in chicks vaccinated against H9N2 avian influenza, primarily by promoting intestinal targeting and IgA production. This innovation addresses longstanding challenges in achieving effective mucosal responses with traditional and emerging vaccine platforms.

• Applied Workflows with HyperScribe All in One mRNA Synthesis

  2026-05-21

  The HyperScribe All in One mRNA Synthesis Kit Plus 1 delivers rapid, immune-evasive, ARCA-capped mRNA optimized for RNA vaccines, in vitro translation, and RNAi. This guide translates cutting-edge experimental findings into actionable workflow enhancements and troubleshooting strategies for streamlined mRNA synthesis.

• Pyroptosis-Related Gene Signatures Reveal GSDMC as a Target

  2026-05-21

  Yan et al. present a systems-based prognostic model for pancreatic adenocarcinoma (PAAD) rooted in pyroptosis-related gene expression, highlighting GSDMC as a key therapeutic target. Their integrative approach provides actionable insights for risk stratification and drug sensitivity prediction in PAAD.

• Applied Strategies with PCI-32765 Ibrutinib in B-Cell Resear

  2026-05-20

  PCI-32765 (Ibrutinib) stands out as a benchmark BTK inhibitor for dissecting B-cell receptor signaling and malignant cell viability. This guide delivers stepwise protocols, troubleshooting insights, and cross-model enhancements, enabling precision in chronic lymphocytic leukemia and autoimmune disease research.

• BMX-IN-1: Unlocking BMX Kinase Inhibition for Translational

  2026-05-20

  Explore the mechanistic and translational significance of BMX-IN-1, a highly selective BMX kinase inhibitor. This article bridges the latest host-pathogen insights with strategic guidance for cancer and infectious disease researchers, highlighting BMX kinase’s pivotal role in lysosomal acidification, apoptosis induction, and cell cycle arrest. Practical protocol guidance and a clear roadmap for integrating BMX-IN-1 into advanced models are provided.

• Advancing Hazardous Bioaerosol Detection by Removing Pollen

  2026-05-19

  This study presents a robust approach for eliminating pollen spectral interference in excitation–emission matrix fluorescence spectroscopy, significantly improving the classification accuracy of hazardous bioaerosols. The integration of advanced spectral transformations and machine learning enhances rapid detection, supporting improved public health surveillance.

• Alfuzosin Hydrochloride (A5173): Reliable Solutions for Lab

  2026-05-19

  This scenario-driven guide addresses key laboratory challenges in cell viability and smooth muscle research. Using Alfuzosin Hydrochloride (SKU A5173), the article demonstrates evidence-backed strategies for reproducibility, assay sensitivity, and reliable data, providing actionable protocols and candid vendor selection insights.

• Pemetrexed: Multi-Targeted Antifolate for Tumor Cell Studies

  2026-05-18

  Pemetrexed is a potent antifolate antimetabolite widely used in cancer chemotherapy research. It inhibits multiple folate-dependent enzymes essential for nucleotide biosynthesis, demonstrating robust antiproliferative effects in tumor cell lines.

419 records 8/28 page Previous Next First page 上5页 678910 下5页 Last page